Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ameren (AEE) EBT (2016 - 2025)

Ameren has reported EBT over the past 17 years, most recently at $244.0 million for Q4 2025.

  • Quarterly results put EBT at $244.0 million for Q4 2025, up 61.59% from a year ago — trailing twelve months through Dec 2025 was $1.6 billion (up 25.75% YoY), and the annual figure for FY2025 was $1.6 billion, up 25.75%.
  • EBT for Q4 2025 was $244.0 million at Ameren, down from $693.0 million in the prior quarter.
  • Over the last five years, EBT for AEE hit a ceiling of $693.0 million in Q3 2025 and a floor of $151.0 million in Q4 2024.
  • Median EBT over the past 5 years was $293.0 million (2022), compared with a mean of $330.7 million.
  • Biggest five-year swings in EBT: fell 23.74% in 2024 and later soared 61.59% in 2025.
  • Ameren's EBT stood at $155.0 million in 2021, then rose by 23.87% to $192.0 million in 2022, then grew by 3.12% to $198.0 million in 2023, then decreased by 23.74% to $151.0 million in 2024, then soared by 61.59% to $244.0 million in 2025.
  • The last three reported values for EBT were $244.0 million (Q4 2025), $693.0 million (Q3 2025), and $320.0 million (Q2 2025) per Business Quant data.